Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 17 | 2004 | 276 | 0.910 |
Why?
|
| Ambulatory Care | 8 | 2000 | 229 | 0.450 |
Why?
|
| Dyskinesia, Drug-Induced | 8 | 1999 | 23 | 0.400 |
Why?
|
| Antipsychotic Agents | 10 | 2004 | 247 | 0.370 |
Why?
|
| Psychiatric Status Rating Scales | 10 | 2000 | 346 | 0.360 |
Why?
|
| Schizophrenic Psychology | 9 | 2000 | 71 | 0.310 |
Why?
|
| Depressive Disorder | 5 | 1999 | 368 | 0.310 |
Why?
|
| Cognition Disorders | 5 | 2004 | 240 | 0.160 |
Why?
|
| Psychotic Disorders | 4 | 2004 | 144 | 0.160 |
Why?
|
| Congenital Abnormalities | 1 | 1997 | 112 | 0.140 |
Why?
|
| North Carolina | 1 | 2015 | 52 | 0.140 |
Why?
|
| Neurologic Examination | 1 | 1995 | 76 | 0.130 |
Why?
|
| Age Factors | 9 | 2000 | 1195 | 0.130 |
Why?
|
| Bipolar Disorder | 1 | 1995 | 211 | 0.120 |
Why?
|
| Neuropsychological Tests | 5 | 2004 | 363 | 0.120 |
Why?
|
| Electronic Health Records | 1 | 2015 | 205 | 0.110 |
Why?
|
| Substance Withdrawal Syndrome | 3 | 1995 | 179 | 0.110 |
Why?
|
| Alzheimer Disease | 2 | 1997 | 367 | 0.110 |
Why?
|
| Middle Aged | 19 | 2004 | 13070 | 0.110 |
Why?
|
| Jugular Veins | 1 | 2012 | 35 | 0.110 |
Why?
|
| Femoral Vein | 1 | 2012 | 45 | 0.110 |
Why?
|
| Carotid Arteries | 1 | 2012 | 82 | 0.110 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 431 | 0.100 |
Why?
|
| Femoral Artery | 1 | 2012 | 122 | 0.100 |
Why?
|
| Aging | 1 | 1997 | 784 | 0.100 |
Why?
|
| Brief Psychiatric Rating Scale | 5 | 2004 | 7 | 0.090 |
Why?
|
| Mental Disorders | 1 | 1995 | 451 | 0.090 |
Why?
|
| Male | 22 | 2012 | 27312 | 0.090 |
Why?
|
| Factor Analysis, Statistical | 3 | 2004 | 76 | 0.090 |
Why?
|
| Humans | 26 | 2015 | 54246 | 0.090 |
Why?
|
| Aged | 14 | 2004 | 10041 | 0.080 |
Why?
|
| Clonidine | 1 | 1988 | 24 | 0.080 |
Why?
|
| Female | 20 | 2012 | 28418 | 0.080 |
Why?
|
| Growth Hormone-Releasing Hormone | 1 | 1988 | 22 | 0.080 |
Why?
|
| Psychometrics | 3 | 1999 | 241 | 0.080 |
Why?
|
| Growth Hormone | 1 | 1988 | 78 | 0.080 |
Why?
|
| Prospective Studies | 6 | 2012 | 2604 | 0.070 |
Why?
|
| Smoking | 1 | 1988 | 555 | 0.060 |
Why?
|
| Self Concept | 1 | 2003 | 70 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 1997 | 1304 | 0.060 |
Why?
|
| Severity of Illness Index | 5 | 2004 | 1084 | 0.050 |
Why?
|
| Geriatric Assessment | 2 | 1999 | 126 | 0.050 |
Why?
|
| Adult | 10 | 2004 | 14182 | 0.050 |
Why?
|
| Mood Disorders | 1 | 1999 | 63 | 0.040 |
Why?
|
| Sucrase-Isomaltase Complex | 1 | 1999 | 1 | 0.040 |
Why?
|
| Sucrase | 1 | 1999 | 3 | 0.040 |
Why?
|
| Longitudinal Studies | 3 | 1997 | 746 | 0.040 |
Why?
|
| Depression | 2 | 2003 | 594 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1999 | 218 | 0.040 |
Why?
|
| Age of Onset | 4 | 1999 | 116 | 0.040 |
Why?
|
| Analysis of Variance | 3 | 1999 | 635 | 0.040 |
Why?
|
| Alcoholism | 2 | 1996 | 249 | 0.030 |
Why?
|
| Movement Disorders | 1 | 1995 | 18 | 0.030 |
Why?
|
| Double-Blind Method | 3 | 1999 | 742 | 0.030 |
Why?
|
| Isometric Contraction | 1 | 1995 | 25 | 0.030 |
Why?
|
| Incidence | 2 | 1997 | 1082 | 0.030 |
Why?
|
| Observer Variation | 1 | 1995 | 138 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 1995 | 167 | 0.030 |
Why?
|
| Video Recording | 1 | 1995 | 90 | 0.030 |
Why?
|
| AIDS Dementia Complex | 1 | 1994 | 3 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 1995 | 431 | 0.030 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2004 | 83 | 0.030 |
Why?
|
| Survival Analysis | 1 | 1995 | 735 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 1998 | 1604 | 0.030 |
Why?
|
| Comorbidity | 1 | 1995 | 663 | 0.030 |
Why?
|
| Risk Factors | 3 | 1997 | 3930 | 0.030 |
Why?
|
| Sensation | 1 | 1992 | 15 | 0.030 |
Why?
|
| Neural Inhibition | 1 | 1992 | 26 | 0.030 |
Why?
|
| Hip | 1 | 2012 | 26 | 0.030 |
Why?
|
| Prevalence | 1 | 1995 | 1022 | 0.030 |
Why?
|
| Patient Positioning | 1 | 2012 | 35 | 0.030 |
Why?
|
| Acute Disease | 2 | 1995 | 403 | 0.030 |
Why?
|
| Rotation | 1 | 2012 | 76 | 0.030 |
Why?
|
| Body Height | 1 | 2012 | 76 | 0.030 |
Why?
|
| Sex Factors | 3 | 1999 | 765 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 1992 | 234 | 0.020 |
Why?
|
| Clinical Trials as Topic | 2 | 1995 | 490 | 0.020 |
Why?
|
| Gestational Age | 1 | 2012 | 435 | 0.020 |
Why?
|
| Educational Status | 3 | 1999 | 259 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2012 | 480 | 0.020 |
Why?
|
| Body Weight | 1 | 2012 | 578 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2012 | 335 | 0.020 |
Why?
|
| Irritable Mood | 1 | 1988 | 8 | 0.020 |
Why?
|
| Akathisia, Drug-Induced | 1 | 1988 | 13 | 0.020 |
Why?
|
| Drug Evaluation | 1 | 1988 | 27 | 0.020 |
Why?
|
| Hunger | 1 | 1988 | 23 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 1988 | 63 | 0.020 |
Why?
|
| Random Allocation | 1 | 1988 | 312 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 1543 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 1988 | 231 | 0.020 |
Why?
|
| Placebos | 2 | 1999 | 90 | 0.020 |
Why?
|
| Reference Values | 1 | 1988 | 354 | 0.020 |
Why?
|
| Length of Stay | 2 | 2004 | 683 | 0.020 |
Why?
|
| Anxiety | 1 | 1988 | 278 | 0.020 |
Why?
|
| Regression Analysis | 2 | 1998 | 445 | 0.020 |
Why?
|
| Hospitalization | 2 | 2004 | 705 | 0.020 |
Why?
|
| Pilot Projects | 1 | 1988 | 808 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2012 | 2907 | 0.020 |
Why?
|
| Drug Administration Schedule | 2 | 1995 | 401 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2000 | 1679 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2004 | 3429 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 1999 | 1136 | 0.010 |
Why?
|
| Recurrence | 2 | 1995 | 690 | 0.010 |
Why?
|
| Adolescent | 3 | 2004 | 6885 | 0.010 |
Why?
|
| Time Factors | 1 | 1988 | 3212 | 0.010 |
Why?
|
| Logistic Models | 1 | 2003 | 990 | 0.010 |
Why?
|
| Pain | 1 | 2003 | 405 | 0.010 |
Why?
|
| Cholinergic Antagonists | 1 | 1999 | 6 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 1999 | 34 | 0.010 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 1999 | 4 | 0.010 |
Why?
|
| Hydrogen | 1 | 1999 | 13 | 0.010 |
Why?
|
| Sucrose | 1 | 1999 | 30 | 0.010 |
Why?
|
| Breath Tests | 1 | 1999 | 44 | 0.010 |
Why?
|
| Concept Formation | 1 | 1998 | 11 | 0.010 |
Why?
|
| Diarrhea | 1 | 1999 | 90 | 0.010 |
Why?
|
| Milk | 1 | 1999 | 94 | 0.010 |
Why?
|
| California | 1 | 1997 | 90 | 0.010 |
Why?
|
| Disease Progression | 1 | 2000 | 913 | 0.010 |
Why?
|
| Kinetics | 1 | 1999 | 692 | 0.010 |
Why?
|
| Quality of Life | 1 | 2003 | 922 | 0.010 |
Why?
|
| Learning | 1 | 1998 | 175 | 0.010 |
Why?
|
| Thorax | 1 | 1996 | 15 | 0.010 |
Why?
|
| Tremor | 1 | 1996 | 17 | 0.010 |
Why?
|
| Extremities | 1 | 1996 | 27 | 0.010 |
Why?
|
| Mouth | 1 | 1996 | 35 | 0.010 |
Why?
|
| Schizophrenia, Paranoid | 1 | 1995 | 4 | 0.010 |
Why?
|
| Face | 1 | 1996 | 66 | 0.010 |
Why?
|
| Marital Status | 1 | 1995 | 20 | 0.010 |
Why?
|
| Psychoses, Substance-Induced | 1 | 1995 | 8 | 0.010 |
Why?
|
| Social Adjustment | 1 | 1995 | 31 | 0.010 |
Why?
|
| Meta-Analysis as Topic | 1 | 1995 | 39 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 1996 | 156 | 0.010 |
Why?
|
| Prognosis | 1 | 2000 | 2118 | 0.010 |
Why?
|
| Thioridazine | 1 | 1994 | 12 | 0.010 |
Why?
|
| Intelligence Tests | 1 | 1994 | 44 | 0.010 |
Why?
|
| Haloperidol | 1 | 1994 | 41 | 0.010 |
Why?
|
| Family | 1 | 1995 | 191 | 0.010 |
Why?
|
| Parietal Lobe | 1 | 1992 | 30 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1992 | 76 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 1992 | 56 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 1992 | 99 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1992 | 69 | 0.010 |
Why?
|
| Infant | 1 | 1999 | 3817 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1999 | 4146 | 0.010 |
Why?
|
| Brain | 1 | 1998 | 1387 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1995 | 2387 | 0.010 |
Why?
|
| Child | 1 | 1999 | 7337 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1998 | 6432 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 1995 | 5604 | 0.000 |
Why?
|
| Animals | 1 | 1999 | 14385 | 0.000 |
Why?
|